Catherine wanted to build a career in accounting so she chose to study AAT with us. Read her experience below.

Jasmin left her corporate job to pursue a career as a Nail Technician, she is currently studying the Level 2 Certificate in ...

Sanofi’s recombinant AAT therapy, efdoralprin alfa (formerly INBRX-101), met all primary and secondary endpoints in its Phase II study. The treatment showed superiority to plasma-derived therapy and ...

Emmerdale fans are very much here for Ned Porteous ’ new look. The actor returned to his role as Joe Tate last Christmas. As ...

Independent accountancy firm Robson Laidler has welcomed eight new trainees across its Newcastle, Durham and Teesside offices ...

Beam Therapeutics Inc. trades at a relatively cheap valuation based on its multiples and potential in SCD. Learn more about ...

Positive results from the global ElevAATe Phase II study have shown that efdoralprin alfa met all primary and key secondary endpoints when dosed every three weeks (Q3W) or four weeks (Q4W) in adults ...

Some seniors say the Social Security Administration's cost-of-living adjustment won’t help much in their ability to pay for ...